- Home
- CRIS vs OXBR Comparison
CRIS vs OXBR Comparison
Compare CRIS & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRIS | OXBR |
|---|---|---|
| Founded | 2000 | 2013 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9M | 11.0M |
| IPO Year | 2000 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CRIS | OXBR |
|---|---|---|
| Price | $0.93 | $1.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $16.50 | $5.00 |
| AVG Volume (30 Days) | ★ 453.2K | 14.9K |
| Earning Date | 11-06-2025 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,650,000.00 | $2,423,000.00 |
| Revenue This Year | $6.13 | $497.99 |
| Revenue Next Year | $7.86 | $42.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.56 | N/A |
| 52 Week Low | $0.77 | $0.99 |
| 52 Week High | $3.55 | $5.81 |
Technical Indicators
Market Signals| Indicator | CRIS | OXBR |
|---|---|---|
| Relative Strength Index (RSI) | 44.87 | 31.73 |
| Support Level | $0.82 | $1.01 |
| Resistance Level | $0.96 | $1.13 |
| Average True Range (ATR) | 0.09 | 0.08 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 41.71 | 6.67 |
Price Performance
Historical ComparisonAbout CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About OXBR Oxbridge Re Holdings Limited
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.